Table 1 Basic information on the ULM specimens used for the xenograft models in this study.

From: Effects of female hormone withdrawal and ulipristal acetate on MED12 mutation positive and negative uterine leiomyomas using a xenograft model

ULM ID

MED12 mutation

Age

Major axis

x

Minor axis

(mm x mm)

Type

Single

(S)

Surgical method

Collagen fiber ratio (%)

SMC ratio (%)

Multiple (M)

MED12m(+)-ULM

ULM#11

c.131G> A, p.G44D

27

64 × 62

Subserous

S

LM

46.7

56.6

ULM#14

c.131G> A, p.G44D

49

35 × 30

Subserous

M

TLH

47.8

50.6

ULM#15

c.131G> C, p.G44A

36

75 × 64

Intramural

M

LM

48.1

51.0

ULM#16

c.131G> A, p.G44D

30

37 × 28

Subserous

M

LM

40.8

41.2

ULM#18

c.131G> T, p.G44V

30

42 × 38

Submucosal

M

LM

49.7

69.0

ULM#22

c.131G> T, p.G44V

43

144 × 96

Intramural

M

TLH

46.0

68.6

ULM#27

c.131G> T, p.G44V

34

74 × 68

Intramural

M

LM

52.5

72.8

ULM#29

c.131G> T, p.G44V

45

35 × 35

Intramural

M

TLH

45.9

75.6

ULM#30

IVS1-11_131del43

41

ND

Intramural

M

LM

42.4

67.5

ULM#39

c.130G> A, p.G44S

49

42 × 36

Intramural

M

AT

56.9

62.7

ULM#40

c.131G> A, p.G44D

39

28 × 23

Intramural

M

LM

43.1

54.0

Mean ± SD

 

38.5 ± 7.7

58 × 48

   

47.3 ± 4.6

60.9 ± 10.9

MED12m(-)-ULM

ULM#12

-

47

29 × 23

Intramural

M

TLH

29.6

82.2

ULM#13

-

40

83 × 35

Intramural

S

TLH

46.6

81.0

ULM#19

-

47

80 × 69

Intramural

M

TLH

12.6

81.6

ULM#20

-

42

81 × 74

Intramural

S

TLH

36.8

75.4

ULM#24

-

41

50 × 50

Submucosal

S

TLH

32.2

84.4

ULM#25

-

49

115 × 62

Intramural

M

TLH

49.6

75.5

ULM#26

-

46

45 × 39

Submucosal

S

TLH

20.5

81.8

ULM#31

-

37

52 × 52

Intramural

M

LH

23.6

86.4

ULM#37

-

46

71 × 70

Submucosal

S

RAH

22.1

87.1

ULM#38

-

49

37 × 26

Intramural

S

TLH

20.5

81.8

ULM#46

-

44

60 × 50

Intramural

S

RAH

21.8

87.1

Mean ± SD

 

44.4 ± 3.9

64 × 50

   

28.7 ± 11.6

82.2 ± 4.0

  1. AT; abdominal simple total hysterectomy, LH; laparoscopic hysterectomy, LM; laparoscopic myomectomy, RAH; robotic-assisted total hysterectomy, SMC; smooth muscle cell, TLH; total laparoscopic hysterectomy.